These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3120561)

  • 1. Nitroglycerin in chronic stable angina pectoris.
    Reichek N
    Am J Cardiol; 1987 Nov; 60(15):15H-17H. PubMed ID: 3120561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal effects of intravenous nitroglycerin over 24 hours.
    Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
    Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.
    Kimchi A; Lee G; Amsterdam E; Fujii K; Krieg P; Mason DT
    Circulation; 1983 Jan; 67(1):124-7. PubMed ID: 6401172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial.
    Sato H; Koretsune Y; Taniguchi T; Fukui S; Shimazu T; Sugii M; Matsuyama T; Karita M; Hori M
    Arzneimittelforschung; 1997 Feb; 47(2):128-31. PubMed ID: 9079231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Am J Cardiol; 1997 Jul; 80(2):128-31. PubMed ID: 9230146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ointments and transdermal nitroglycerin patches for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):625-33. PubMed ID: 7848897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
    Dalal JJ; Parker JO
    Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
    Pizzulli L; Hagendorff A; Zirbes M; Jung W; Lüderitz B
    Am J Cardiol; 1997 Jan; 79(1):28-33. PubMed ID: 9024731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
    Flaherty JT
    Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianginal effects of nitroglycerin patches.
    Reichek N; Priest C; Zimrin D; Chandler T; Sutton MS
    Am J Cardiol; 1984 Jul; 54(1):1-7. PubMed ID: 6430053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sublingual nitroglycerin on the gas exchange response to exercise in stable angina pectoris.
    Sullivan M; Myers J; Buchanan N; Froelicher V
    Am J Cardiol; 1993 Oct; 72(11):767-9. PubMed ID: 8213507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of buccal nitroglycerin and sublingual nitroglycerin in the prophylaxis and treatment of exertional (situation-provoked) angina pectoris.
    Bray CL; Jain S; Faragher EB; Myers A; Myers P; MacIntyre P; Rae A; Goldman M; Alcorn M
    Eur Heart J; 1991 May; 12 Suppl A():16-20. PubMed ID: 1908385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
    Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
    Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic efficacy of 10 mg of nitroglycerin patch in stable angina pectoris.
    Rezaković DE; Stalec J
    Am J Cardiol; 1988 Mar; 61(9):52E-58E. PubMed ID: 3126636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
    de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
    Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.